US NewsA box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, on Oct. 31, 2023. Lee Smith/ReutersReuters3/3/2026|Updated: 3/3/20260:00The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster diabetes drug, Ozempic, saying the commercial makes false and misleading claims about the drug’s benefits.It is the second time in less than a month that the FDA has warned the Danish drugmaker about its misleading ads.
-5.1
C
Ottawa
Wednesday, March 4, 2026
The Alliance Press is the world leader in online chained news and information and seeks to inform, engage and empower the world. We expose the information that wasn't known before or current events broadcast over the radio, television, online or in print media. Our content is now available through your mobile phone. No matter where your on-the-go lifestyle takes you, TAP brings the news directly to you.
More from CN
Contact
© The Alliance Media Group design by CODEUS